Literature DB >> 3233801

Relation between serum digoxin concentration and the electrocardiogram.

H E Saner1, H W Lange, C A Pierach, D M Aeppli.   

Abstract

The relation between serum digoxin concentration and the electrocardiogram was assessed by correlating computerized measurements of electrocardiographic parameters (PR, QRS, QT and QTc intervals, ST segment, and T-wave amplitude) with the serum digoxin concentration in 97 patients on digoxin maintenance therapy and in 40 nondigitalized control subjects. None of the patients had unstable ischemic heart disease, electrolyte disorders, medication known to influence the ST segment, and/or the presence of a bundle-branch block or ventricular hypertrophy. We found a trend toward lengthened PR interval and shortened QT and QTc intervals in digitalized versus nondigitalized patients. Increasing serum digoxin concentrations were associated with progressive depression of the ST segment and decreased T-wave amplitude (p less than 0.001). A normal ST segment in four leads (I, aVF, V5, V6) excluded the presence of a serum digoxin concentration greater than 1.3 ng/ml in our patients, whereas severe ST-segment depression with a J point of greater than or equal to 100 microV was a strong indicator for the presence of a serum digoxin concentration greater than 2.0 ng/ml in our selected patient population (specificity 99%, sensitivity 30%, predictive accuracy 85%). We conclude that computerized electrocardiographic analysis of the ST segment may provide clinically useful information for the management of selected patients on digitalis therapy and may therefore increase the diagnostic yield of the electrocardiogram in predicting the presence of higher serum digoxin concentrations in a small but significant percentage of patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233801     DOI: 10.1002/clc.4960111106

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Facts, fancies and follies of drug-induced QT/QTc interval shortening.

Authors:  Marek Malik
Journal:  Br J Pharmacol       Date:  2010-01       Impact factor: 8.739

Review 2.  Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

3.  Detecting Digoxin Toxicity by Artificial Intelligence-Assisted Electrocardiography.

Authors:  Da-Wei Chang; Chin-Sheng Lin; Tien-Ping Tsao; Chia-Cheng Lee; Jiann-Torng Chen; Chien-Sung Tsai; Wei-Shiang Lin; Chin Lin
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

4.  Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.

Authors:  Susanne Rehnelt; Daniela Malan; Krisztina Juhasz; Benjamin Wolters; Leo Doerr; Matthias Beckler; Ralf Kettenhofen; Heribert Bohlen; Tobias Bruegmann; Philipp Sasse
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.